Skip to content

Analysis of osseointegration of implants with different macrogeometries: a randomized clinical trial

Analysis of osseointegration of implants with a new macrogeometry: randomized clinical trial in split mouth

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-96n5x69
Enrollment
Unknown
Registered
2023-06-19
Start date
2021-07-07
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osseointegration

Interventions

this split-mouth randomized clinical trial analyzed the insertion of 30 implants in the posterior region of the mandible of 15 patients, comparing the implant stability quotient values of two groups o

Sponsors

pontifícia universidade católica do paraná
Lead Sponsor
pontifícia universidade católica do paraná
Collaborator

Eligibility

Age
21 Years to No maximum

Inclusion criteria

Inclusion criteria: partial edentulous patients in the posterior region of the mandible requiring one implant in each half-arch or two implants in each half-arch;minimum bone height of 11 mm and minimum bone thickness of 5 mm in the posterior region of the bilateral mandible evaluated by means of cone beam computed tomography; sufficient prosthetic space for subsequent prosthetic rehabilitation

Exclusion criteria

Exclusion criteria: the need for some type of bone reconstruction or advanced surgery to allow the installation of the implant; patients who did not accept to be part of the study; patients with uncontrolled diabetes, considering glycated hemoglobin above 7.5%; smokers more than 10 cigarettes a day; use of oral or injectable bisphosphonates; immunodeficient patients; patients who underwent radiotherapy in the head and neck region for a period of less than five years before the beginning of the research; patients with another systemic condition that contraindicated performing oral surgery at the time or who had conditions that could interfere with the osseointegration process

Design outcomes

Primary

MeasureTime frame
Expected outcome 1: the ISQ (implant stability quotient) value at the end of 42 days was expected to be higher in the test group than in the control group.;Outcome found 1: The ISQ (implant stability quotient) value at the end of 42 days had no significant difference between the tested groups.

Countries

Brazil

Contacts

Public ContactPatricia Souza

Pontifícia Universidade Católica do Paraná

patytolentino@gmail.com+55 41 3271-1555

Outcome results

None listed

Source: REBEC (via WHO ICTRP)